BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 165831)

  • 1. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood.
    Patterson WD; Hardman JG; Sutherland EW
    Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
    Pichard AL; Cheung WY
    J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent multiple forms of cyclic AMP phosphodiesterase from rat erythrocytes.
    Patterson WD; Hardman JG; Sutherland EW
    Mol Cell Endocrinol; 1976; 5(1-2):51-66. PubMed ID: 182574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.
    McElroy FA; Philip RB
    Life Sci; 1975 Nov; 17(9):1479-93. PubMed ID: 173959
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.
    Hait WN; Weiss B
    Biochim Biophys Acta; 1977 Mar; 497(1):86-100. PubMed ID: 14711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J; Lachance B; Hamet P
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
    Minneman KP
    J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma cyclic AMP level and cAMP phosphodiesterase activity in Takayasu's disease (author's transl)].
    Nlmano F; Kochi K; Arita M; Tamaki H; Numano F
    Nihon Naika Gakkai Zasshi; 1976 Oct; 65(10):1020-5. PubMed ID: 12238
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 15. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma.
    Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts.
    Takemoto DJ; Lee WN; Kaplan SA; Appleman MM
    J Cyclic Nucleotide Res; 1978 Apr; 4(2):123-32. PubMed ID: 207751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes.
    Wedner HJ
    Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
    Hidaka H; Asano T; Shimamoto T
    Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.